Device Trial Radar · NCT01700114
Post-Approval Study of MelaFind
Last checked: Nov 20, 2026Latest source record: Mar 11, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- MELA Sciences, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 4, 2012
Design
- Study type
- Observational
- Who can join
- All sexes
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to collect data to describe the real-world use and safety and effectiveness of MelaFind® in a post-approval clinical setting.
Conditions
- Melanoma
Interventions
MelaFindDevice
The device is used when a dermatologist chooses to obtain additional information on atypical skin lesions for a decision to biopsy.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Relative sensitivity comparing enrolling dermatologists after MelaFind use with enrolling dermatoligsts if MelaFind were not availableTime frame: 6 years
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
AboutSkin Dermatology and DermSurgery
Englewood, Colorado
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.